Krystal Biotech (KRYS) Amortizatization of Intangibles (2019 - 2020)
Krystal Biotech (KRYS) reported Amortizatization of Intangibles of $26000.0 for Q1 2020, down 61.19% on a YoY basis from $67000.0 in Q2 2019, and little changed sequentially from $26000.0 in Q4 2019.
Krystal Biotech (KRYS) Amortizatization of Intangibles (2019 - 2020) Analysis & Trends
Krystal Biotech (KRYS) has 2 years of Amortizatization of Intangibles data on file, last reported at $26000.0 in Q1 2020.
- For the quarter ending Q1 2020, Amortizatization of Intangibles fell 61.19% year-over-year to $26000.0; the trailing twelve-month figure through Mar 2020 stood at $185000.0 (changed N/A YoY), and the FY2023 full-year result was -$1.3 million, down 190.51% from the prior year.
- Amortizatization of Intangibles was little changed at $26000.0 in Q1 2020, from $26000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $68000.0 in Q3 2019 to a low of $26000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Krystal Biotech | 10.38 Bn | 9.56 Bn | 110.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 26,000.00 |
| Mar 31, 2020 | 26,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Sep 30, 2019 | 68,000.00 |
| Sep 30, 2019 | 68,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Mar 31, 2019 | 67,000.00 |
| Mar 31, 2019 | 67,000.00 |